NTC presents the Value report 2021 to its stakeholders - NTC Pharma

Follow us on LinkedIn

NTC España website

NTC España website

NTC Novelty, Technology, Care

Search ...

NTC

Home
About NTC
Partnering
Therapeutic Solutions
Ethics & Transparency
News & Events
Careers
Contact us

NTC España website

NTC España website

Follow us on LinkedIn

Home
About NTC
Novelty, Technology, Care

Our Strategy

Corporate Reporting

Quality is a Value

Leadership Team

Sustainability
Partnering
BD&L Team

NTC 4 you
Therapeutic Solutions
Ophthalmology

Eye Surgery

Eye Infections

Eye Inflammations

Dry Eye Disease

Allergy

Blepharitis

Corneal Oedema

Ocular Discomforts

Vitreal Trophism

Glaucoma

Gastro - Metabolism

Colonoscopy

Nutritional Disorders

Hepatic Disorders

Pediatrics

Iron Supplementation

Nutritional disorders

Immune system

Canker Sores

Wound care

Gynaecology

Vulvovaginal discomfort

Hormonal activity regulation

Iron deficiency

Constipation

Pipeline
Ethics & Transparency
Corporate Liability

Code of Conduct

Transfer of Values

Whistleblowing
News & Events
Careers
Contact us

NTC presents the Value report 2021 to its stakeholders

NTC presents the Value report 2021 to its stakeholders

July 29, 2021

TERM OF USE PRIVACY POLICY COOKIE POLICY WHISTLEBLOWING PHARMACOVIGILANCE

NTC Headquarters

Via dei Gracchi, 35
20146 Milano (Italy)

+39 02 438 5041

Contact us now!

NTC Registered Office

Via Razza, 3
20124 Milano – Italy

Follow us on LinkedIn

©2022 Ntc s.r.l. | Sole quotaholder | Share capital € 8.000.000,00 | Taxpayer ID and VAT number IT03503980967